ID: MRFR/MED/5031-HCR | February 2021 | Region: Global | 100 pages
Smart Medical Devices market Appraise To Reach USD 23.50 Billion by 2027 End, At a CAGR of 23.5%.
The advent of advanced technology is aiding pharmaceutical and biotechnological companies in developing safer routes for administration of biologics and other drugs that are delivered through intravenous infusion. As per the report published by Market Research Future (MRFR), introduction of technologically advanced Smart Medical Devices is resulting in the significant growth of the Smart Medical Devices Market in the forthcoming years. The conversion of commercialized patient-centric biologics from intravenous infusion to subcutaneous injection has opened multiple growth opportunities for the Smart Medical Devices Market. Owing to the high emphasis on self-administration of biologics and inclination towards adoption of single-use Smart Medical Devices, the Smart Medical Devices Market is projecting high growth potential during the assessment period.
Prevalence of lifestyle-associated disorders and diseases that demand round-the-clock monitoring of physiological parameters are inducing high demand for easy-to-use Smart Medical Devices. Furthermore, the integration of advanced Bluetooth technology with Smart Medical Devices is aiding the physicians and medical practitioners with real-time access to the device in order to minimize errors. The optional smart functionality and less time utilization by Smart Medical Devices are some other benefits that are leading to the quick acceptance of Smart Medical Devices, which in turn is propelling the expansion of the Smart Medical Devices Market.
This MRFR market study delivers an unbiased analysis of key trends in the Smart Medical Devices Market. It also includes a discussion on the current status of market, historical trends, growth opportunities and challenges backed by factual feedbacks. The primary types of Smart Medical Devices that have been assessed in the report include on-body, off-body and hand-held Smart Medical Devices. The technologies covered in the report are spring-based, motor-driven, rotary pump, expanding battery and others. For opportunity analysis, major application areas that are covered in the report are oncology, diabetes, auto-immune disorders, cardiovascular diseases and others. All the sub-market covered in the report are profiled under four major region- North America, Europe, Asia Pacific and the rest of the world, with respective country-level analysis.
The report on the Smart Medical Devices Market covers market dynamics, historical market trends, key player's market share analysis, market value by segmentation as well as region, country-level break down for each market segment, key players' market share analysis, competitive landscape and supply chain analysis.
Some of the prominent players operating in the Smart Medical Devices Market are Becton Dickinson and Company, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Amgen, Inc., Unilife Corporation, Debiotech S.A., SteadyMed Therapeutics, Inc., Insulet Corporation, Enable Injections, Sensile Medical AG, West Pharmaceutical Services, Inc., and CeQur SA.
Market Research Future (MRFR) employs a multi-layered and proven research methodology to ensure the deliverance of comprehensive market insights by critically observing and extrapolating the current and historical market trends. The combination of primary and secondary research processes ensures the authenticity and reliability of market insights. First-hand interviews and surveys are conducted for primary data collection. Secondary research process is utilized to verify the primary data through inputs from white paper references, paid database, research publications, SEC filings and other sources available in public domain. Utilization of strong data triangulation method and top-down and bottom-up approaches ensures the rich quality and objectivity of the market foresight.
Smart Medical Devices Market Segmental Analysis
For the scope of research, MRFR's report offers a detailed segmental analysis of the Smart Medical Devices Market
|Market Size||2027: USD 23.50 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||By Type, By Technology By Application and By End-Use|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Becton Dickinson and Company, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Amgen, Inc., Unilife Corporation, Debiotech S.A., SteadyMed Therapeutics, Inc., Insulet Corporation, Enable Injections, Sensile Medical AG, West Pharmaceutical Services, Inc., and CeQur SA|
|Key Market Opportunities||The conversion of commercialized patient-centric biologics from intravenous infusion to subcutaneous injection.|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The types included in smart medical devices market are Off-body (belt clip), On-body (adhesive patch), and Hand-held.
The report on smart medical devices market includes the motor-driven, spring-based, expanding battery, rotary pump, collapsible reservoir, pressurized gas, and others.
The smart medical devices market report includes segments like infectious diseases, diabetes, oncology, cardiovascular diseases, auto-immune disorders, and others.
The end users of smart medical devices market are a hospital, clinic, home care settings, ambulatory surgery centers, and others.
The players involved in the smart medical devices market are Johnson & Johnson Services, Inc., Becton Dickinson and Company, Amgen, Inc., F. Hoffmann-La Roche Ltd., Debiotech S.A., SteadyMed Therapeutics, Inc., Unilife Corporation, Enable Injections, Insulet Corporation, West Pharmaceutical Services, Inc., Sensile Medical AG, and CeQur SA.